Certified Research Associates, is an affiliate of Smith Allergy & Asthma Specialists of Central NY. The Center was opened in June 2017 by founder Dr. Christopher Smith to assist with the evaluation of new medications, treatments, and protocols for allergies, asthma, COPD and vaccinations.
Participating in clinical trials is a powerful way to contribute to the advancement of medical research and innovation. By becoming a clinical trial volunteer, you play a crucial role in helping researchers discover new treatments, improve existing therapies, and enhance our understanding of various health conditions. Clinical trials are carefully controlled and regulated to ensure participant safety while exploring cutting-edge medical solutions. As a volunteer, you’ll not only gain access to advanced healthcare options but also join a community dedicated to making a tangible impact on the future of medicine. Your involvement could lead to breakthroughs that benefit millions, so consider taking a step toward joining a clinical trial today.
EMBARQ-CSU Research Study
What is EMBARQ-CSU?
CSU is the medical term for chronic hives that last for 6 weeks or longer where there is no obvious external trigger such as cold, heat, pressure, water, substance, exercise, and stress. It presents as a skin reaction with itchy welts that can be small or large.
You may qualify for the EMBARQ-CSU research study if:
- You are 18 years of age or older
- Have a confirmed (documented) CSU diagnosis ≥ 6 months prior to Screening
- Your symptoms have not been adequately controlled with commonly prescribed treatments like antihistamines
Those who qualify may receive:
- Reimbursement for travel
- Study-related care from local doctors and specialists
- No-cost study medication
If you or someone you know are interested in more information or volunteering, please contact Danielle Allen, LPN, CCRC @ 607.218.5202 or email dallen@smithallergy.com.
Acadia Research Study
What is the Acadia Study?
This study is comparing how well budesonide/albuterol or albuterol works as a rescue inhaler in adolescents with asthma. Adding an inhaled corticosteroid (ICS) such as budesonide into rescue inhalers helps to relieve asthma symptoms and prevent flare-ups in adults. To understand whether this also works for adolescents, we will compare: A rescue inhaler without an ICS (albuterol alone) A rescue inhaler with an ICS (budesonide/albuterol combined) Budesonide and albuterol are separately approved in children as young as 1 year old. Budesonide/albuterol is approved in adults.
You may qualify if you are:
- You are 12-17 years old
- Use a daily inhaler
- Have needed to use a rescue inhaler
Those who qualify may receive:
- Reimbursement for travel
- Study-related care from local doctors and specialists
- No-cost study medication
If you or someone you know are interested in more information or volunteering, please contact Danielle Allen, LPN, CCRC @ 607.218.5202 or email dallen@smithallergy.com.